Low levels of C-peptide have clinical significance for established Type 1 diabetes
Author:
Affiliation:
1. Immunobiology Laboratory; Harvard Medical School and Massachusetts General Hospital; Boston MA USA
2. Department of Biostatistics; Massachusetts General Hospital; Boston MA USA
Funder
The Iacocca Foundation
NIH BADRC
Publisher
Wiley
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/dme.12850/fullpdf
Reference30 articles.
1. The case for blood glucose control;Genuth;Advances Intern Med,1995
2. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group [see comments];DCCT.Research.Group;N Engl J Med,1993
3. Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial;Steffes;Diabetes Care,2003
4. Complications of type 1 diabetes;Melendez-Ramirez;Endocrinol Metab Clin North Am,2010
5. Residual beta-Cell function 3-6 years after onset of type 1 diabetes reduces risk of severe hypoglycemia in children and adolescents;Sorensen;Diabetes Care,2013
Cited by 93 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The rare DRB1*04:08-DQ8 haplotype is the main HLA class II genetic driver and discriminative factor of Early-onset Type 1 diabetes in the Portuguese population;Frontiers in Immunology;2024-01-03
2. Residual Secretion of C-Peptide in Type 1 Diabetes Mellitus: What is Its Metabolic Impact?;2023-11-16
3. Fasted C-Peptide Distribution and Associated Clinical Factors in Adults With Longstanding Type 1 Diabetes: Analysis of the Canadian Study of Longevity in Type 1 Diabetes;Canadian Journal of Diabetes;2023-11
4. Troxerutin as an anti-inflammatory and anti-oxidative drug could ameliorate Type 1 diabetes complications in C57BL/6 mice;Journal of the Hellenic Veterinary Medical Society;2023-10-18
5. Simplification of Complex Insulin Regimens with IdegLira in People with Type 2 Diabetes: Literature Review and Clinical Recommendations;Diabetes Therapy;2023-09-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3